Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma

被引:48
|
作者
Yu, JunJie [1 ]
Mao, WeiPu [1 ]
Sun, Si [1 ]
Hu, Qiang [1 ]
Wang, Can [1 ]
Xu, ZhiPeng [1 ]
Liu, RuiJi [1 ]
Chen, SaiSai [1 ]
Xu, Bin [2 ]
Chen, Ming [2 ,3 ]
机构
[1] Southeast Univ, Coll Med, Nanjing, Peoples R China
[2] Southeast Univ, Dept Urol, Affiliated Zhongda Hosp, Nanjing, Peoples R China
[3] Southeast Univ, Dept Urol, Affiliated Lishui Peoples Hosp, Nanjing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
prognostic signature; The Cancer Genome Atlas; long non-coding RNA; kidney renal clear cell carcinoma; M6A; PARTIAL NEPHRECTOMY; NONCODING RNAS; EXPRESSION; CANCER;
D O I
10.3389/fonc.2021.663263
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study aimed to construct an m6A-related long non-coding RNAs (lncRNAs) signature to accurately predict the prognosis of kidney clear cell carcinoma (KIRC) patients using data obtained from The Cancer Genome Atlas (TCGA) database. Methods The KIRC patient data were downloaded from TCGA database and m6A-related genes were obtained from published articles. Pearson correlation analysis was implemented to identify m6A-related lncRNAs. Univariate, Lasso, and multivariate Cox regression analyses were used to identifying prognostic risk-associated lncRNAs. Five lncRNAs were identified and used to construct a prognostic signature in training set. Kaplan-Meier curves and receiver operating characteristic (ROC) curves were applied to evaluate reliability and sensitivity of the signature in testing set and overall set, respectively. A prognostic nomogram was established to predict the probable 1-, 3-, and 5-year overall survival of KIRC patients quantitatively. GSEA was performed to explore the potential biological processes and cellular pathways. Besides, the lncRNA/miRNA/mRNA ceRNA network and PPI network were constructed based on weighted gene co-expression network analysis (WGCNA). Functional Enrichment Analysis was used to identify the biological functions of m6A-related lncRNAs. Results We constructed and verified an m6A-related lncRNAs prognostic signature of KIRC patients in TCGA database. We confirmed that the survival rates of KIRC patients with high-risk subgroup were significantly poorer than those with low-risk subgroup in the training set and testing set. ROC curves indicated that the prognostic signature had a reliable predictive capability in the training set (AUC = 0.802) and testing set (AUC = 0.725), respectively. Also, we established a prognostic nomogram with a high C-index and accomplished good prediction accuracy. The lncRNA/miRNA/mRNA ceRNA network and PPI network, as well as functional enrichment analysis provided us with new ways to search for potential biological functions. Conclusions We constructed an m6A-related lncRNAs prognostic signature which could accurately predict the prognosis of KIRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
    Zhang, Zhenyu
    Wang, Fangkai
    Zhang, Jianlin
    Zhan, Wenjing
    Zhang, Gaosong
    Li, Chong
    Zhang, Tongyuan
    Yuan, Qianqian
    Chen, Jia
    Guo, Manyu
    Xu, Honghai
    Yu, Feng
    Wang, Hengyi
    Wang, Xingyu
    Kong, Weihao
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [2] Identification of cuproptosis-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma
    He, Ya
    Zhang, Hongxia
    Li, Jingang
    Zhou, Hui
    Wang, Fei
    Zhang, Guangliang
    Wen, Yuetao
    JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2024, 22 (01):
  • [3] Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
    Zhang, Yue
    Zhuang, Tongtian
    Xin, Zhenlong
    Sun, Changjian
    Li, Deyang
    Ma, Nan
    Wang, Xiaoyan
    Wang, Xuning
    CELLS, 2023, 12 (01)
  • [4] Identification of m6A-Related lncRNA to Predict the Prognosis of Patients with Hepatocellular Carcinoma
    Yang, Hao
    Yang, Hong
    Zhang, Wei
    Wang, Juping
    Sun, Liping
    Gao, Juan
    Zhao, Haiping
    Wang, Zhenfei
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [5] Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients
    Yu, JunJie
    Mao, WeiPu
    Xu, Bin
    Chen, Ming
    CANCER MEDICINE, 2021, 10 (07): : 2359 - 2369
  • [6] Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma
    Lin, Wentao
    Tan, Zhou-yong
    Fang, Xi-chi
    SLAS TECHNOLOGY, 2024, 29 (01): : 100101
  • [7] Identification and validation of an m5C-related lncRNA signature for predicting prognosis and immune response in clear cell renal cell carcinoma
    Ao, Shan
    Liang, Leqi
    Peng, Lei
    Yang, Riwei
    Chen, Zugen
    Deng, Tuo
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [8] A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
    Xin, Sheng
    Mao, Jiaquan
    Cui, Kai
    Li, Qian
    Chen, Liang
    Li, Qinyu
    Tu, Bocheng
    Liu, Xiaming
    Wang, Tao
    Wang, Shaogang
    Liu, Jihong
    Song, Xiaodong
    Song, Wen
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [9] Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma
    Hua, Xiaoliang
    Chen, Juan
    Su, Yang
    Liang, Chaozhao
    AGING-US, 2020, 12 (03): : 2302 - 2332
  • [10] A Novel m6A-Related LncRNA Signature for Predicting Prognosis, Chemotherapy and Immunotherapy Response in Patients with Lung Adenocarcinoma
    Shen, Yefeng
    Wang, Shaochun
    Wu, Yuanzhou
    CELLS, 2022, 11 (15)